IP International Journal of Ocular Oncology and Oculoplasty
Official Publication of Khyati Education And Research Foundation
Official Publication of Khyati Education And Research Foundation
IP International Journal of Ocular Oncology and Oculoplasty (IJOOO) open access, peer-reviewed quarterly journal publishing since 2016 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article ‘Ahead of Print’ immediately on acceptance. In addition, the journal would allow free access (Open Access) to its contents, which is likely to attract more readers and citations to articles published in IJOOO.
Manuscripts must be prepared in accordance with “Uniform requirements” of the IP International Journal of Ocular Oncology and Oculoplasty as per guidelines by the International Committee of Medical Journals Editors (Updated December 2019). The uniform requirements and specific requirements of IJOOO are mentioned below. Before sending a manuscript contributors are requested to check for the author guidelines, which are available on the website of the journal (www.ijooo.org/info/author) or directly from the (Manuscript Peer-Review Process called MPRP) manuscript submission website https://www.mprp.in/journals/IJOOO
The aim and commitment of the journal are to publish a research-oriented manuscript address significant issues in all the subjects and areas of Ocular Oncology and Oculoplasty. Journal is committed itself to improve Education and Research on Blurred Vision, Cataract, Macular Degeneration, Glaucoma, Diabetic Retinopathy, Refractive Error, Internal Medicine, Pediatrics, General Surgery, Eye Pathology, Eye Diseases, Implement Laser Therapy, Dry Eyes, Strabismus (Misalignment/Deviation of Eyes), Proptosis (Bulged Eyes), Excessive Tearing (Tear Duct Obstruction), Uveitis, Eye Tumors, Lacrimal Apparatus, Eye Removal, Orbital Reconstruction, Blepharoplasty, Ptosis, Ectropion, Entropion, Epicanthoplasty, Tarsorrhaphy, etc.
Index Copernicus, Google Scholar, J- gate, ROAD, CrossRef, Microsoft Academic, Indian Citation Index (ICI), Scilit.
Journal is committed to upholding the highest standards of ethical behaviour at all stages of publication. We strictly adhere to the industry associations such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE), and World Association of Medical Editors (WAME), which set standards and provide guidelines for best practices in order to meet these requirements. To know more about specific policies regarding duplicate publication, conflict of interest, patient consent, etc., please visit the author guidelines
The journal promotes open access publishing that can be refers to free, unrestricted online access to research outputs such as journals, articles and books. OA content is open to all without any accessing fees without paying a subscription charge. Articles are freely available immediately after publication without any registration. This means the researchers, students, readers, scholars, and any layperson from anywhere and anytime have rapid access to the latest research content via Innovative Open Access (OA) Policy. For more details and information, visit: www.ipinnovative.com/open-access-journals
The journal is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License (CC BY-NC-SA 4.0), which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. This license allows authors to grant certain permissions to others while retaining certain rights for themselves.
Authors can deposit their published article in any repository. After publication of the article in the journal, authors are allowed and encouraged to submit their content online (for example, in institutional repositories or on their website). As this can result in fruitful discussions and earlier and more frequent citation of published work which can help to promote the accessibility and reproducibility of research findings for others.
The journal takes a signed copy of the consent declaration form authors where they sign and accepts responsibility for releasing this material to the publisher on behalf of any and all co-authors. But author retains the copyright of the content and transfers all the licensing and publishing rights to the publisher. The author grants the publisher the only right to commercially utilize the article. For the duration of the copyright's full legal term, they provide the publisher, exclusive right, and license to publish. This transfer of publication rights covers the non-exclusive right to reproduction and distribute the article, including reprints, translations, photographic, reproductions, microform, electronic form (offline, online) or any other reproduction of similar nature.
Self-plagiarism is the redundant reuse of your own work, “use another’s production without crediting the sources,” or “present as new and original an idea or product derived from an existing source.” The IJOOO also considers “self-plagiarism” as a form of plagiarism. An example of self-plagiarism would be when an author borrows from his or her own previously published work without the proper citation within the newly submitted manuscript. We provide iThenticate software to our editor and reviewers as a part of our manuscript submission system.
Digital archiving ensures the preservation and accessibility of digital content over time, safeguarding it from technological changes and data loss. We prioritize the longevity and integrity of our journal by utilizing leading digital archiving services Portico and CLOCKSS. Our journal are securely preserved and remain accessible to researchers, educators, and the public, today and in the future.
The Journal retains the discretion to decline any advertisement that does not meet journal advertising policy.
1. Advertisements will not be accepted if they are indecent, offensive, or discriminatory based on personal, racial, ethnic, sexual orientation, or religious grounds, whether in text or artwork.
2. The Journal will not accept advertisements for products or services known to be harmful to health, such as tobacco and alcohol.
3. Product advertorials will not allow any treatment-specific or drug-specific campaigns to target specific articles related to the advertised products.
The presence of advertisements or product information on the Journal's website does not means endorsement or approval by the Journal or its publisher regarding the quality or claims made by the manufacturer of the advertised products. Editorial decision does not depend on the any advertisement visible on the website.
Articles published online under the “Ahead of Print” model are considered published and can be cited and quoted using DOI as the reference source. Innovative Publication has a policy that changes WILL NOT be made after the publication of an article. Unless an accepted procedure for making corrections to the scientific record is followed.
IP International Journal of Ocular Oncology and Oculoplasty is a self-financed open access journal, which is published in both online and print versions. Article publication charges levied on authors are the only source of income that is utilized in maintaining the administrative and print charges. Also, the very least part of revenue comes from advertisements and subscriptions.
The APC is based on an adjusted scale, providing reduced rates for low- and middle-income countries on the publication charges. Operating expense including the cost of web presence, print version, pre-press preparations, and staff salaries is supported by the above-mentioned resources.
KERF has outsourced all pre-publication, publication, and post-publication processes to the publisher, including APC management.
Please visit for APC details
IP Innovative Publication Private Limited, is a well-established publisher headquartered in New Delhi, India. IP has a reputed specialization in medical, dental, nursing, and pharmacy subjects and has more than 225 books and 50 journals in its portfolio. It was founded in April 2011 and has become a well-respected medical publisher in India that fully supports many of the popular open-access models through its peer-review management system. Researchers, students, scholars, clinicians, and other healthcare professionals access Innovative journals from around the globe to educate themselves about new and innovative discoveries and to improve patient care. For more info about the publisher, click here
Print and Online Scholarly Publisher, Peer-review system, Specialized in Medical, Dental, Nursing, and Pharmacy books and Journals as an Open Access (OA) Publisher.